News
SNDL
1.740
+4.82%
0.080
Is SNDL Inc Gaining or Losing Market Support?
Benzinga · 12/29/2025 18:00
Weekly Report: what happened at SNDL last week (1222-1226)?
Weekly Report · 12/29/2025 09:09
'Federal Health Programs Will Cover Up To $500 Worth Of CBD For Certain Patients By April, Trump Official Dr. Oz Says'- Marijuana Moment
Benzinga · 12/24/2025 15:49
Trump reportedly seeks finalization of marijuana rescheduling by January-end
Seeking Alpha · 12/24/2025 13:12
'President Trump Directs Attorney General Pam Bondi to Finalize Marijuana Rescheduling by the End of January'- The Marijuana Herald
Benzinga · 12/23/2025 19:55
'Supreme Court Should Uphold Gun Ban For Marijuana Users, 19 State AGs Tell Justices' - Marijuana Moment
Benzinga · 12/23/2025 17:18
Weekly Report: what happened at SNDL last week (1215-1219)?
Weekly Report · 12/22/2025 09:09
Trump Signs Order To Ease Federal Marijuana Restrictions: Here Is Why Cannabis Stocks Soared And Then Fell
Benzinga · 12/19/2025 02:28
Cannabis stocks selling off amid Trump’s rescheduling order
Seeking Alpha · 12/18/2025 18:55
Trump Order Will Direct Maintaining Restrictions On Dangerous Products; Centers For Medicare & Medicaid Services Plans To Allow Beneficiaries To Benefit From Hemp-derived Cbd Products At No Cost; Trump Order Will Not Encourage Use, But Recognizes Potential Both Therapeutic Uses And Risks Like Addiction; Marijuana Will Remain Illegal To Possess Under Federal Law; Trump Order Makes No Changes To Criminal Penalties Or Access For Recreational Use Of Marijuana
Benzinga · 12/18/2025 18:51
Trump To Sign Executive Order On Thursday Aiming To Expedite Reclassification Of Marijuana As Schedule III Substance; Trump Order Will Allow More Research Of Medical Marijuana And Cannabidiol; Trump Order Will Help U.s. To Better Understand Risks Associated With Marijuana; There Is Currently Insufficient Evidence Of Marijuana's Medical Uses; Trump Order Will Direct White House To Work With Congress To Improve Access To Hemp-Derived CBD Products
Benzinga · 12/18/2025 18:49
'Trump's Marijuana Executive Order Details Leaked Ahead Of Announcement, Including CBD And Hemp Provisions'- Marijuana Moment
Benzinga · 12/18/2025 17:50
White House Considers Cannabis Reclassification, Stops Short Of Legalization: Stocks To Watch
Benzinga · 12/17/2025 17:07
'Trump's Marijuana Rescheduling Order Could Include Industry Banking And CBD Medicare Coverage Provisions, Sources Say;'- Marijuana Moment
Benzinga · 12/17/2025 17:01
High Hopes: Pot Stocks Blaze As Trump Eyes Rescheduling
Benzinga · 12/17/2025 16:26
Pot stocks rally as Trump expected to sign executive order on rescheduling
Seeking Alpha · 12/17/2025 14:26
'Trump to sign executive order reclassifying marijuana: Officials' -ABC Report
Benzinga · 12/17/2025 13:38
Wall Street Is Betting That SNDL Stock Can More Than Double in the Next Year. Should You Buy Shares Here?
Barchart · 12/17/2025 12:50
'Trump Expected To Sign An Order Moving To Reclassify Cannabis And Open Up Medical Potential' - NBC News
Benzinga · 12/17/2025 09:12
Trump Weighs Marijuana Changes: 'A Lot Of People Want To See It'
Benzinga · 12/15/2025 23:18
More
Webull provides a variety of real-time SNDL stock news. You can receive the latest news about SNDL INC through multiple platforms. This information may help you make smarter investment decisions.
About SNDL
SNDL Inc., through its wholly owned subsidiaries, is a vertically integrated cannabis company and a private-sector liquor and cannabis retailer in Canada. Its retail banners include Ace Liquor, Wine and Beyond, Liquor Depot, Value Buds and Spiritleaf. With products available in licensed cannabis retail locations nationally, its consumer-facing cannabis brands include Top Leaf, Contraband, Palmetto, Bon Jak, La Plogue, Versus, Value Buds, Grasslands, Vacay, Pearls by Gron, No Future and Bhang Chocolate. Its liquor retail segment includes the sales of wines, beers and spirits. Its cannabis retail segment includes the sales of cannabis products and accessories through corporate-owned and franchised cannabis retail operations. Its cannabis operations segment operates as a licensed producer that grows cannabis using indoor facilities and manufactures cannabis products, providing cannabis processing services. Its investments segment includes deployment of capital to investment opportunities.